The use of androgenic steroids, peptides and other performance- and image-enhancing drugs is becoming common for some groups of Australian males, placing their health at risk and presenting challenges to health professionals.
Patients may not reveal their use of performance- and image-enhancing drugs for various reasons, which may complicate the diagnosis and treatment of related health problems. The complex combinations and patterns of use of performance- and image-enhancing drugs can cause further complications.
Practitioners who are aware of patients’ use of performance- and image-enhancing drugs must avoid complicity.
The ultimate goal of care for users of performance- and image-enhancing drugs should be cessation, with treatment of adverse effects and counselling until that time.
Identify anabolic-androgenic steroids and related substances commonly used for performance or image enhancement, and the harms associated with use.
Outline the key motivations and contextual factors driving anabolic steroid use among different populations.
Describe clinical signs and symptoms that may indicate use of performance and image-enhancing drugs and any related complications.
Apply evidence-informed approaches to the assessment, management, and treatment of patients experiencing anabolic steroid-related harms.
Describe strategies for patient engagement, harm reduction, and referral to specialist services where appropriate.
This is a Medcast Continuing Medical Education (CME) course.
This course is formally accredited with RACGP and ACRRM.
RACGP Activity ID: 1379018
ACCRM Activity ID: 38517

Live Webinar
10/12/2025 7:00 pm (Sydney time)
Australia/Sydney
Duration: 1 HR CPD
Educational Activities: 1 hours
Program Level Requirements: Professionalism and Ethical Practice
Areas Of Interest: Men's health
Medical Practitioners
Or follow us on social media
All your CPD in one easy membership.
From $35/month